Back to mobile site

Teva Pharma (TEVA) PT Lowered to $40 at BofA Securities

April 30, 2026 4:35 AM EDT Send to a Friend
BofA Securities analyst Jason Gerberry lowered the price target on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login